Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$332K Hold
917
0.02% 92
2026
Q1
$323K Buy
917
+12
+1% +$4.28K 0.02% 91
2025
Q4
$296K Hold
905
0.02% 115
2025
Q3
$255K Sell
905
-52
-5% -$15.1K 0.01% 102
2025
Q2
$267K Hold
957
0.02% 97
2025
Q1
$298K Hold
957
0.02% 88
2024
Q4
$249K Hold
957
0.01% 92
2024
Q3
$308K Hold
957
0.02% 86
2024
Q2
$299K Hold
957
0.02% 83
2024
Q1
$272K Hold
957
0.02% 80
2023
Q4
$276K Hold
957
0.02% 82
2023
Q3
$257K Buy
+957
New +$239K 0.02% 83

Other funds holding AMGN

E.S. Barr & Co's AMGN Position: Q2 2026 in Review

E.S. Barr & Co held its Amgen (AMGN) position steady in Q2 2026 at 917 shares worth $332K. The position accounts for 0.02% of the portfolio, ranked #92.

E.S. Barr & Co first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • E.S. Barr & Co held 917 shares of Amgen worth $332K as of Q2 2026.
  • E.S. Barr & Co left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.02% of E.S. Barr & Co's portfolio in Q2 2026, its #92 holding.
  • E.S. Barr & Co first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on E.S. Barr & Co's 13F filing for Q2 2026, filed 13 Aug 2026.